Condition: Treatment Resistant Depression · Sponsor: Washington University School of Medicine
Electroconvulsive therapy (ECT) alleviates treatment-resistant depression (TRD) through repeated generalized seizures. The goal of this study is to evaluate how ECT impacts sleep-wake regulation and efficiency of information transfer in functional networks in different states of arousal.
This description comes directly from the study's public registry record.
Robby Greenspan · 314-273-6129 · greenspan@wustl.edu
MohammadMehdi Kafashan · 314-273-8848 · kafashan@wustl.edu
Always discuss trial participation with your own doctor first.
| Washington University School of Medicine/Barnes-Jewish Hospital | St Louis, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05905705